Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: kapur g. Kidney Int. 2021 Jul;100(1):225-237. doi: 10.1016/j.kint.2020.10.046. Epub 2020 Dec 8. Kidney Int. 2021. PMID: 33307104 Free article. Clinical Trial.
Atypical hemolytic uremic syndrome: a clinical conundrum.
Bajracharya P, Jain A, Baracco R, Mattoo TK, Kapur G. Bajracharya P, et al. Among authors: kapur g. Pediatr Nephrol. 2016 Oct;31(10):1615-24. doi: 10.1007/s00467-016-3369-6. Epub 2016 May 2. Pediatr Nephrol. 2016. PMID: 27139899
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: kapur g. Kidney Int. 2023 Jul;104(1):205. doi: 10.1016/j.kint.2023.04.010. Kidney Int. 2023. PMID: 37349053 Free article. No abstract available.
Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study.
Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA. Gipson DS, et al. Among authors: kapur g. Health Qual Life Outcomes. 2013 Mar 4;11:30. doi: 10.1186/1477-7525-11-30. Health Qual Life Outcomes. 2013. PMID: 23510630 Free PMC article.
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study.
Selewski DT, Massengill SF, Troost JP, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA, Gipson DS. Selewski DT, et al. Among authors: kapur g. Pediatr Nephrol. 2014 Dec;29(12):2347-56. doi: 10.1007/s00467-014-2858-8. Epub 2014 Jun 9. Pediatr Nephrol. 2014. PMID: 24908324 Free PMC article.
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.
Selewski DT, Troost JP, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Song PX, Reeve BB, DeWalt DA, Gipson DS. Selewski DT, et al. Among authors: kapur g. Pediatr Nephrol. 2015 Sep;30(9):1467-76. doi: 10.1007/s00467-015-3074-x. Epub 2015 Mar 18. Pediatr Nephrol. 2015. PMID: 25784017 Free PMC article.
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.
Selewski DT, Troost JP, Cummings D, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Carlozzi NE, Reeve BB, DeWalt DA, Gipson DS. Selewski DT, et al. Among authors: kapur g. Health Qual Life Outcomes. 2017 Aug 23;15(1):166. doi: 10.1186/s12955-017-0737-2. Health Qual Life Outcomes. 2017. PMID: 28835233 Free PMC article.
Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.
Zahr RS, Yee ME, Weaver J, Twombley K, Matar RB, Aviles D, Sreedharan R, Rheault MN, Malatesta-Muncher R, Stone H, Srivastava T, Kapur G, Baddi P, Volovelsky O, Pelletier J, Gbadegesin R, Seeherunvong W, Patel HP, Greenbaum LA. Zahr RS, et al. Among authors: kapur g. Pediatr Nephrol. 2019 Aug;34(8):1435-1445. doi: 10.1007/s00467-019-04237-3. Epub 2019 Apr 3. Pediatr Nephrol. 2019. PMID: 30945006
Survey of Telemedicine by Pediatric Nephrologists During the COVID-19 Pandemic.
Raina R, Nair N, Yap HK, Filler G, Sethi SK, Bagga A, Hari P, Bunchman T, Bartosh S, Twombley K, Kapur G, McCulloch M, Warady BA, Díaz-González de Ferris M, Rush S. Raina R, et al. Among authors: kapur g. Kidney Int Rep. 2021 Jul 7;6(9):2316-2322. doi: 10.1016/j.ekir.2021.06.026. eCollection 2021 Sep. Kidney Int Rep. 2021. PMID: 34514192 Free PMC article.
80 results